Unbiased AI-powered news
President Trump intervened in a regulatory dispute over vaping products, supporting tobacco companies against a position held by his own administration's officials. The Food and Drug Administration commissioner resigned in protest following the decision. The New York Times reported the tobacco industry had contributed to groups supporting Trump.
rediff.comOne official, the FDA commissioner, resigned in protest after the intervention. The tobacco companies involved had contributed to groups affiliated with Trump. Officials at the FDA had been advancing restrictions on certain vaping products before the president's involvement.
The action marks a direct intervention by the president in an ongoing regulatory process at the agency. It remains unclear how the decision will alter specific rules on vape sales or marketing. The resignation of the commissioner followed the resolution of the dispute in favor of the industry position.
Tobacco companies provided financial support to groups connected to Trump ahead of the regulatory decision. No specific amounts or timing details beyond the general connection were provided in the reporting. The FDA had been examining measures that could have tightened controls on vaping devices and liquids.
Industry representatives had opposed those measures. Trump's decision aligned with the companies' objections rather than the agency's earlier direction.
Single source — no framing comparison available.
Los Angeles TimesThe Defense Department reinstated required flu vaccinations for new recruits after an outbreak at Lackland Air Force Base sickened nearly 300 people. The reversal ends a policy that had made the shots optional for the first time in 70 years.
Nbc NewsSens. Kirsten Gillibrand and Eric Schmitt urged Defense Secretary Peter Hegseth to remove rules limiting Applied Behavior Analysis therapy under TRICARE. The letter followed an NBC News report detailing coverage denials for military families. It seeks to designate the therapy as…
upi.comThe legislation would let drugmakers issue retroactive rebates and impose new rules on hospitals and contract pharmacies. Separately, the Trump administration is considering Jeff Vacirca to lead the FDA.